Abstract
Background: Unconventional Knoevenagel-type indoles have been the topic of interest of many synthetic chemists because of its promising efficacy in different diseases including cancer.
Objective: To explore the structural requirements of Knoevenagel-type cytotoxic indoles for higher efficacy.
Methods: Multi-QSAR modeling (MLR, ANN, SVM, Bayesian classification, HQSAR and Topomer CoMFA) was performed on these analogs.
Results: All these modeling techniques were validated individually and interpreted with the experimental SAR observations. Phenyl or p-methoxyphenyl substitution at 2nd position, electron withdrawing groups (such as sulphonyl, cyano etc.) at 3rd position and methoxy substation at 5th position of the indole scaffold may favor cytotoxicity. Eight new indole molecules were predicted from the developed QSAR models.
Conclusion: These newly designed compounds may bind to the colchicine binding site of the tubulin protein as suggested by the molecular docking study.
Keywords: Knoevenagel-type indoles, cytotoxic agents, ANN, SVM, Bayesian classification model, HQSAR, Topomer CoMFA, molecular docking.
Graphical Abstract
Current Computer-Aided Drug Design
Title:An Integrated Multi-QSAR Modeling Approach for Designing Knoevenagel- Type Indoles with Enhancing Cytotoxic Profiles
Volume: 13 Issue: 4
Author(s): Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha*Shovanlal Gayen*
Affiliation:
- Natural Science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, P.O. Box 17020, Jadavpur University, Kolkata 700032, (WB),India
- Laboratory of Drug Design and Discovery, Department of Pharmaceutical Sciences, Dr. Harisingh Gour University (A Central University), Sagar 470003, (MP),India
Keywords: Knoevenagel-type indoles, cytotoxic agents, ANN, SVM, Bayesian classification model, HQSAR, Topomer CoMFA, molecular docking.
Abstract: Background: Unconventional Knoevenagel-type indoles have been the topic of interest of many synthetic chemists because of its promising efficacy in different diseases including cancer.
Objective: To explore the structural requirements of Knoevenagel-type cytotoxic indoles for higher efficacy.
Methods: Multi-QSAR modeling (MLR, ANN, SVM, Bayesian classification, HQSAR and Topomer CoMFA) was performed on these analogs.
Results: All these modeling techniques were validated individually and interpreted with the experimental SAR observations. Phenyl or p-methoxyphenyl substitution at 2nd position, electron withdrawing groups (such as sulphonyl, cyano etc.) at 3rd position and methoxy substation at 5th position of the indole scaffold may favor cytotoxicity. Eight new indole molecules were predicted from the developed QSAR models.
Conclusion: These newly designed compounds may bind to the colchicine binding site of the tubulin protein as suggested by the molecular docking study.
Export Options
About this article
Cite this article as:
Amin Abdul Sk. , Adhikari Nilanjan , Jha Tarun *, Gayen Shovanlal *, An Integrated Multi-QSAR Modeling Approach for Designing Knoevenagel- Type Indoles with Enhancing Cytotoxic Profiles, Current Computer-Aided Drug Design 2017; 13 (4) . https://dx.doi.org/10.2174/1573409913666170309150014
DOI https://dx.doi.org/10.2174/1573409913666170309150014 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelets as Potential Link Between Diabetes and Alzheimer's Disease
Current Alzheimer Research Chest Pain, Panic Disorder and Coronary Artery Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Editorial (Alzheimer’s Disease and Frail Syndrome: Features Overlap Predictive of Poor Outcome)
CNS & Neurological Disorders - Drug Targets ADF/Cofilin-Actin Rods in Neurodegenerative Diseases
Current Alzheimer Research NLRP3 Inflammasome Activation Leading to IL-1 – IL-17 Dependent Lung Inflammation and Fibrosis
Current Respiratory Medicine Reviews Acute Methamphetamine and Benzylpiperazine Decrease Aggression- Related Behavior in Late Adolescent Male Rats
Current Psychopharmacology Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective
Recent Patents on Anti-Infective Drug Discovery Magnetic Materials for the Selective Analysis of Peptide and Protein Biomarkers
Current Medicinal Chemistry CRF Receptors as a Potential Target in the Development of Novel Pharmacotherapies for Depression
Current Pharmaceutical Design Memories are Made of This (Perhaps): A Review of Serotonin 5-HT6 Receptor Ligands and Their Biological Functions
Current Topics in Medicinal Chemistry Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design Vagotomy and Gastric Tumorigenesis
Current Neuropharmacology Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Proteomics Studies in Oncology Towards Personalized Medicine in Public Health: Opportunities and Challenges for OMICS Research in Iran
Current Pharmacogenomics and Personalized Medicine Retina Repair, Stem Cells and Beyond
Current Neurovascular Research Structure, Function and Interactions of Tau: Particular Focus on Potential Drug Targets for the Treatment of Tauopathies
CNS & Neurological Disorders - Drug Targets Neonatal Abstinence Syndrome Management: A Review of Recent Evidence
Reviews on Recent Clinical Trials In Vitro Skin Permeation Enhancement of Sumatriptan by Microneedle Application
Current Drug Delivery Histamine H3 Receptor (H3R) Antagonists and Inverse Agonists in the Treatment of Sleep Disorders
Current Pharmaceutical Design